Daily Dilution Report - Mar 18, 2026
All Events
$BMBL (MC: $440M)
- Common Units: 21.23M Class A shares to be issued to selling stockholders upon exchange of Common Units.
- RSUs: 433K Class A shares to be acquired within 60 days of Feb 27, 2026 through vesting of restricted stock units (Whitney Wolfe Herd).
- Stock Options: 343K Class A shares to be acquired within 60 days of Feb 27, 2026 through exercise of stock options (Whitney Wolfe Herd).
$PAR (MC: $598M)
- New Convertible Notes: $265M principal convertible @ $19.02/share (~16.7M potential shares).
- $33.1M used to repurchase ~2.1M shares @ $15.85/share, funded by new notes.
- $207.5M of existing $212M Convertible Senior Notes due 2027 repurchased with new note proceeds.
$MLAC (MC: $327M)
- Additional Merger Consideration Shares: 4M shares to be issued to Astral.
- Includes 2M shares postponed post-closing & 2M earnout shares subject to conditions.
$DMII (MC: $523M)
- Unsecured convertible note: $150,000 principal, convertible at 35% discount to market price upon business combination.
- Contemplated convertible notes financing: $1,250,000 proposed, with $400,000 funding by 3/30/2026.
$BZH (MC: $626M)
- However, this filing does NOT describe any stock dilution events. The increase in the credit facility is a debt financing matter and does not involve the issuance of new equity or instruments that would dilute existing shareholders.
$TASK (MC: $945M)
- The filing details a Second Amended and Restated Credit Agreement which involves borrowing money through term loans and revolving commitments. This is a debt financing, not an equity financing that would directly dilute existing shareholders by issuing new stock.
- Here's a breakdown of why the listed items are not present or are not dilution events in this filing:
- Warrants: No mention of warrants being issued.